BLUE BIOFUELS, INC.BIOF
Market cap
$54.44M
P/E ratio
| Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
| Net Income (Loss): | -105,010 | -2,304,513 | -4,844,471 | -8,317,260 | -10,262,415 | -2,181,127 | -2,139,310 | -3,960,183 | -3,055,194 | -1,418,981 |
| Depreciation and amortization | - | 5,899 | 233,758 | 73,852 | 85,457 | 40,124 | 131,715 | 138,464 | 216,785 | 118,798 |
| Stock based compensation | - | - | 676,525 | 568,799 | 359,291 | 37,500 | 120,152 | 136,550 | 29,300 | 2 |
| Gain on extinguishment of debt | - | - | - | 528,510 | -675,524 | - | - | - | - | 2 |
| Issuance of warrants for interest expense | - | 902,772 | - | - | - | 876,291 | 104,409 | 2 | 721,705 | 12,450 |
| Loss on disposal of assets | - | - | - | - | - | - | -33,484 | -40,099 | -1,159 | -1,360 |
| Prepaid expenses | -30,000 | 39,142 | -55,829 | -27,351 | 3,286 | -57,041 | -273 | -1,933 | -7,368 | -3,261 |
| Accounts payable | - | - | - | - | - | - | - | - | - | 200,629 |
| Deferred wages and directors’ fees -related party | - | - | - | - | - | - | - | - | - | 779,558 |
| Interest payable - related party | - | - | - | - | - | 99,268 | -49,977 | 26,846 | 67,269 | 42,297 |
| Net cash used in operating activities | -129,841 | 283,931 | -1,768,935 | -2,244,833 | -1,844,227 | -921,446 | -2,465,250 | -2,036,143 | -1,600,411 | -1,003,420 |
| Net purchase of property and equipment | - | 57,168 | 214,225 | 18,037 | 8,000 | - | 216,390 | 138,170 | 287,828 | 71,138 |
| Patent and trademark costs | - | - | - | - | - | - | - | - | 32,677 | 44,653 |
| Net cash from (used in) investing activities | - | -775,168 | -543,874 | -205,572 | -167,128 | -206,315 | -233,132 | -205,520 | -320,505 | -115,791 |
| Net proceeds from issuance of common stock | 39,950 | 194,951 | 1 | 3 | 1 | 887,380 | 2 | 1 | 1 | 197,000 |
| Net proceeds from the issuance of convertible notes — RP | 80,000 | 80,000 | 1 | 500,000 | 1 | - | - | - | 700,000 | 680,000 |
| Net proceeds from the issuance of convertible notes — Other | - | - | - | - | - | 66,330 | - | - | - | 250,000 |
| Proceeds from exercise of warrants and options | - | - | - | - | - | - | - | - | 97,251 | - |
| Net cash provided by financing activities | 129,845 | 551,646 | 2 | 2 | 2 | 1 | 4 | 1 | 2 | 1 |
| Net increase (decrease) in cash and cash equivalents | - | - | - | - | - | 175,949 | 878,085 | -952,763 | -170,893 | 7,789 |
| Interest | - | - | 59,527 | 512,046 | 65,355 | - | - | - | - | - |
| Recognition of operating lease liability and right-of-use asset | - | - | - | - | - | - | - | - | - | 452,132 |
| Issuance of common stock and warrants on the conversion of notes payable | - | - | - | - | - | - | - | - | - | 250,000 |